Indicated for: benign prostatic hyperplasia
Route of administration: oral
Substance: alfuzosin (alpha-1 blocker)
ATC: G04CA01 (Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Alpha-adrenoreceptor antagonists)
Alfuzosin is a medication used to treat symptoms associated with benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate that can cause difficulty urinating. Alfuzosin belongs to the class of alpha-blockers and works by relaxing the smooth muscles in the prostate and bladder neck, making it easier to urinate.
It is taken orally, usually once daily after a meal, to reduce the risk of side effects. Beneficial effects may be noticed within a few days of starting treatment.
Common side effects include dizziness, fatigue, headache, or orthostatic hypotension (a drop in blood pressure when standing up). Patients are advised to avoid sudden movements to prevent dizziness. Alfuzosin is contraindicated in patients with severe liver impairment or those taking other medications that may interact with it. It should be used as directed by a doctor.